Survey 29 - ProstagardMCI Registration NumberFULL NAME (As in your Pancard)EmailPhone/MobileCityStateSpecialityBank DetailsAccount Holder NameA/c NumberIFSC CodeUpload Cancelled Cheque (Max Size - 2 MB)Choose File Pancard NumberUpload Pancard Details (Max Size - 2 MB)Choose File Combination Therapy (Silodosin + Dutasteride) for AUR-Induced BPH Complications in Indian PatientsSection A: Patient Population & Practice Patterns1. In your clinical practice, how frequently do you encounter AUR due to BPH? Rare (Less than 10% of BPH patients) Occasional (10–25%) Common (25–40%) Very common (Greater than 40%)2. What is the most common age group you encounter AUR due to BPH in Indian patients? 50–59 years 60–69 years 70–79 years ≥80 years3. Which comorbidities most often complicate management of AUR in your BPH patients? Diabetes mellitus Hypertension Cardiovascular disease Chronic kidney disease/bladder dysfunctionSection B: Current Treatment Choices4. Which alpha-blocker do you usually prescribe as first-line in BPH with AUR? Tamsulosin Silodosin Alfuzosin Terazosin5. What is your primary pharmacological choice after initial bladder decompression in AUR due to BPH? Alpha-blocker alone 5-alpha reductase inhibitor (5-ARI) alone Combination of alpha-blocker + 5-ARI Immediate surgical consultation6. How often do you currently use Silodosin in routine BPH management (excluding AUR)? Rarely (Less than 10% of cases) Occasionally (10–30%) Often (30–60%) Very frequently (Greater than 60%)Section C: Perceptions on Combination Therapy (Silodosin + Dutasteride)7. In your opinion, how effective is Silodosin + Dutasteride in reducing recurrence of AUR episodes? Not effective Mildly effective Moderately effective Highly effective8. Compared to Tamsulosin + Dutasteride, Silodosin + Dutasteride is perceived as: Less effective Equally effective More effective in AUR reduction Uncertain / insufficient evidence9. How do you rate the speed of symptom relief (IPSS improvement) with Silodosin + Dutasteride? Very slow Moderate Rapid Very rapid10. Which complication do you find Silodosin + Dutasteride most helpful in preventing after AUR? Recurrent retention Need for surgery Progression of LUTS (lower urinary tract symptoms) UTI / bladder stone formationSection D: Safety & Tolerability11. Which adverse event is most frequently observed with Silodosin + Dutasteride in your patients? Retrograde ejaculation/sexual dysfunction Postural hypotension/dizziness Nasal congestion/headache No major side effects12. How well do Indian patients tolerate Silodosin + Dutasteride compared to Tamsulosin + Dutasteride? Better tolerated About the same Less tolerated No clear trend13. In elderly AUR patients (>75 years), how comfortable are you with Silodosin + Dutasteride combination? Very comfortable Moderately comfortable Cautious, prefer alternatives Avoid usageSection E: Real-world Challenges & Outcomes14. What is the most common barrier to prescribing Silodosin + Dutasteride in Indian practice? Cost/affordability Availability Patient adherence Physician familiarity15. What proportion of your BPH with AUR patients avoid surgery with Silodosin + Dutasteride? Greater than 25% 25–50% 50–75% Less than 75%16. How often do patients discontinue therapy due to adverse effects? Greater than 10% 10–20% 20–30% Less than 30%Section E: Real-world Challenges & Outcomes17. Which parameter do you believe shows the greatest improvement with Silodosin + Dutasteride in AUR patients? Qmax (uroflow rate) PVR (post-void residual urine) IPSS storage symptoms IPSS voiding symptoms18. Do you believe early initiation of Silodosin + Dutasteride at first AUR episode can reduce long-term complications? Strongly agree Agree somewhat Neutral Disagree19. In case of recurrent AUR despite medical therapy, your preferred next step is: TURP or surgical intervention immediately Continue dual medical therapy longer Add alternative therapy (phytotherapy, PDE5 inhibitors, etc.) Refer to higher center/urologist20. Going forward, how likely are you to adopt Silodosin + Dutasteride as your standard combination in AUR due to BPH (Indian patients)? Very likely Somewhat likely Uncertain Unlikely I have read and agree to the Terms and Conditions .Submit Form